Diversified Tracked since Q4 FY26 - Q4 FY26

Sai Life Sciences Limited

Compare with...

SAILIFE

Latest quarter Q4 FY26

Revenue ₹602 Cr (+29% YoY)

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

View all executive profiles for Sai Life Sciences Limited

Latest signal bullish high

Sai Life Sciences delivered a strong FY26 with 29% revenue growth, 56% EBITDA growth, and 109% PAT growth, driven by...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q4 FY26 01 May 2026

Revenue ₹602 Cr (+29% YoY)

Sai Life Sciences delivered a strong FY26 with 29% revenue growth, 56% EBITDA growth, and 109% PAT growth, driven by deepening large pharma relationships (19 of top 25...

bullish high

Scorecard starts after historical backfill Read full analysis →